Search Results - "Rolland, F"

First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG) by Ravaud, A., Oudard, S., De Fromont, M., Chevreau, C., Gravis, G., Zanetta, S., Theodore, C., Jimenez, M., Sevin, E., Laguerre, B., Rolland, F., Ouali, M., Culine, S., Escudier, B.

“…Papillary renal cell carcinoma (PRCC), type 1 and type 2, represents 10%–15% of renal cell carcinomas (RCC). There is no standard first-line treatment of…”
Get full text

Does the age at adiposity rebound reflect a critical period? by Rolland‐Cachera, M. F., Cole, T. J.

Get full text

Traumatic incomplete posterior vitreous detachment associated with a form of non-arteritic anterior ischemic optic neuropathy by Urbaing, N., Rolland, F., Boschi, A.

Get full text

Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy by Lefebvre, J. L., Rolland, F., Tesselaar, M., Bardet, E., Leemans, C. R., Geoffrois, L., Hupperets, P., Barzan, L., de Raucourt, D., Chevalier, D., Licitra, L., Lunghi, F., Stupp, R., Lacombe, D., Bogaerts, J., Horiot, J. C., Bernier, J., Vermorken, J. B.

“…Background Both induction chemotherapy followed by irradiation and concurrent chemotherapy and radiotherapy have been reported as valuable alternatives to…”
Get full text

Early adiposity rebound: causes and consequences for obesity in children and adults by Rolland-Cachera, M F, Deheeger, M, Maillot, M, Bellisle, F

“…Childhood obesity is an important public health problem, with a rapidly increasing frequency worldwide. Identification of critical periods for the development…”
Get full text

Impact of the first wave of the COVID-19 pandemic on French Health students by Rolland, F, Frajerman, A, Falissard, B, Bertschy, G, Diquet, B, Marra, D

“…In France, care workers and health students have been intensely mobilized during the first wave of the COVID-19 pandemic. But few studies have evaluated…”
Get more information

Sugar sensing and signalling networks in plants by Rolland, F, Sheen, J

“…Plant sugar signalling operates in a complex network with plant-specific hormone signalling pathways. Hexokinase was identified as an evolutionarily conserved…”
Get more information

Long-term update of the 24954 EORTC phase III trial on larynx preservation by Henriques De Figueiredo, B, Fortpied, C, Menis, J, Lefebvre, J.L, Barzan, L, de Raucourt, D, Geoffrois, L, Giurgea, L, Hupperets, P, Leemans, C.R, Licitra, L, Rolland, F, Tesselaar, M, Vermorken, J.B, Grégoire, V

“…Abstract The long-term results of the EORTC 24954 trial comparing sequential versus alternating chemotherapy and radiotherapy (RT) for patients with locally…”
Get full text

A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen by CULINE, S, THEODORE, C, DE SANTIS, M, BUI, B, DEMKOW, T, LORENZ, J, ROLLAND, F, DELGADO, F.-M, LONGEREY, B, JAMES, N

“…A multicentre phase II trial to determine the efficacy of vinflunine as second-line therapy in patients with advanced transitional cell carcinoma (TCC) of the…”
Get full text

Body mass index growth trajectories associated with the different parameters of the metabolic syndrome at adulthood by Giudici, K V, Rolland-Cachera, M-F, Gusto, G, Goxe, D, Lantieri, O, Hercberg, S, Péneau, S

“…Background: Growth trajectories have shown to be related to obesity and metabolic risks in later life, however body mass index (BMI) trajectories according to…”
Get full text

Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy by Cozzoli, A., Rolland, J.-F., Capogrosso, R. F., Sblendorio, V. T., Longo, V., Simonetti, S., Nico, B., De Luca, A.

“…A. Cozzoli, J.‐F. Rolland, R. F. Capogrosso, V. T. Sblendorio, V. Longo, S. Simonetti, B. Nico and A. De Luca (2011) Neuropathology and Applied Neurobiology37,…”
Get full text

Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial by Fizazi, K., Gravis, G., Flechon, A., Geoffrois, L., Chevreau, C., Laguerre, B., Delva, R., Eymard, J.C., Rolland, F., Houede, N., Laplanche, A., Burcoveanu, D., Culine, S.

“…The standard treatment of patients with metastatic germ-cell tumor (GCT) relapsing after first-line chemotherapy is based on a cisplatin and…”
Get full text

Prevalence of overweight in 6- to 15-year-old children in central/western France from 1996 to 2006: trends toward stabilization by Peneau, S, Salanave, B, Maillard-Teyssier, L, Rolland-Cachera, M.F, Vergnaud, A.C, Mejean, C, Czernichow, S, Vol, S, Tichet, J, Castetbon, K, Hercberg, S

“…Objective: The prevalence of overweight in children has markedly increased over the past few decades in France, as in all Western countries. We sought to…”
Get full text

Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity by Porcelli, Letizia, Quatrale, Anna E., Mantuano, Paola, Leo, Maria G., Silvestris, Nicola, Rolland, Jean F., Carioggia, Enza, Lioce, Marco, Paradiso, Angelo, Azzariti, Amalia

“…Cancer cells may use PARP enzymes and Homologous Recombination to repair single and double strand breaks caused by genotoxic insults. In this study, the PARP-1…”
Get full text

A new electro-optical approach for conductance measurement: an assay for the study of drugs acting on ligand-gated ion channels by Menegon, A., Pitassi, S., Mazzocchi, N., Redaelli, L., Rizzetto, R., Rolland, J. F., Poli, C., Imberti, M., Lanati, A., Grohovaz, F.

“…Ligand gated ion channels are involved in many pathophysiological processes and represent a relevant, although challenging, target for drug discovery. We…”
Get full text

Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases by Loriot, Y., Pagliaro, L., Fléchon, A., Mardiak, J., Geoffrois, L., Kerbrat, P., Chevreau, C., Delva, R., Rolland, F., Theodore, C., Roubaud, G., Gravis, G., Eymard, J.C., Malhaire, J.P., Linassier, C., Habibian, M., Martin, A.L., Journeau, F., Reckova, M., Logothetis, C., Laplanche, A., Le Teuff, G., Culine, S., Fizazi, K.

“…The GETUG 13 phase III trial tested personalised chemotherapy based on tumour marker decline in patients with poor-prognosis germ-cell tumour (GCT) and…”
Get full text

Updated results of GETUG-12, a phase III trial of docetaxel-based chemotherapy in high-risk localized prostate cancer, with a 12-year follow-up by Fizazi, K., Carmel, A., Joly, F., Delva, R., Gravis, G., Rolland, F., Priou, F., Ferrero, J.-M., Houede, N., Mourey, L., Theodore, C., Krakowski, I., Berdah, J.-F., Baciuchka Palmaro, M., Laguerre, B., Flechon, A., Ravaud, A., Brihoum, M., Culine, S., Le Teuff, G.

Get full text

Efficacy and safety of axitinib in metastatic papillary renal carcinoma (mPRC): Results of a GETUG multicenter phase II trial (Axipap) by Negrier, S., Rioux-Leclercq, N., Ravaud, A., Gravis, G., Geoffrois, L., Chevreau, C.M., Rolland, F., Blanc, E., Segura-Ferlay, C., Perol, D., Gross Goupil, M., Dermeche, S., Flechon, A., Albiges, L., Escudier, B.

Get full text

Body mass index in 7-9-y-old French children: frequency of obesity, overweight and thinness by Rolland-Cachera, M.F, Castetbon, K, Arnault, N, Bellisle, F, Romano, M.C, Lehingue, Y, Frelut, M.L, Hercberg, S

“…OBJECTIVE: To assess the frequency of different grades of nutritional status (obesity, overweight and thinness) in French children aged 7-9 y using four…”
Get full text

The ELAN-ONCOVAL (ELderly heAd and Neck cancer-Oncology eValuation) study: Evaluation of the feasibility of a suited geriatric assessment for use by oncologists to classify patients as fit or unfit by Mertens, C., Le Caer, H., Ortholan, C., Blot, E., Even, C., Rousselot, H., Peyrade, F., Sire, C., Cupissol, D., Pointreau, Y., Debourdeau, P., Rolland, F., Fayette, J., Capitain, O., Sun, X., Debbah, M., Schwob, D., Boulahssass, R., Aupérin, A., Guigay, J.

Get full text